Presentation
DIVINCELL is a French Biotech Company, pioneering a novel drug delivery technology for targeted cancer therapies. Our nanoparticle platform enables safe and efficient targeted delivery of therapeutic nucleic compounds. Our lead candidates combine the potency of our nanocarrier with CRISPR and mRNA strategies, to specifically silence KRAS oncogene mutations and rescue tumor suppressor functions.
Contact
divita.gilles@divincell-nanotechnology.fr
Address
LA STATION, 442 rue Georges Besse, 30000 Nîmes
Website
www.divincell-nanotechnology.fr
Targeting innovation : All